期刊文献+

淋巴管癌栓检测及与乳腺癌临床病理特征的关系 被引量:2

Detection of lymph vessel tumor emboli in breast cancer and its relation with clinicopathologic characteristics
下载PDF
导出
摘要 目的比较淋巴管内皮标记物D2-40和HE染色对乳腺癌淋巴管癌栓的检出率以及D2-40阳性的淋巴管癌栓与乳腺癌临床病理特征的关系。方法选取110例浸润性乳腺癌,分别进行HE染色及免疫组化D2-40、CD31、CD34、p63染色;应用SPSS17.0统计软件进行分析。结果 HE染色的淋巴管癌栓检出率为15.5%,假阳性率为2.8%,假阴性率为23.6%;而应用D2-40标记的淋巴管癌栓检出率为36.5%,两者比较差异显著(P<0.05)。淋巴管癌栓与患者的年龄、肿瘤大小、组织学分级、淋巴结转移、ER低表达具有显著的统计学意义,与PR、HER-2表达无统计学意义。结论单克隆抗体D2-40是可靠的淋巴管内皮标记物,与HE染色相比能显著提高淋巴管癌栓的检出率。 Objective To compare lymph vessel tumor emboli(LVTEs) detected by HE and immunohistochemical staining of D2-40 antibodies and to investigate whether D2-40+ LVTE is related with the clinicopathologic characteristics.Methods A total of 110 cases of invasive breast cancer were selected in this study.Lymph vessels were evaluated by immunohistochemistry using the D2-40,CD31,CD34,p63 and HE stain,and software SPSS17.0 was used to analyse the results.Results The positive rate of LVTEs by HE staining was 15.5%,with false-positive rate of 2.8% and false-negative rate of 23.6% by HE staining.LVTEs detected rate by D2-40 was 36.5%,and thus D2-40 staining improveds the rate of LVTEs by 20.9% compared with HE stain.LVTE was positively related to age,tumor size,higher histologic grede,and node status and versely related to ER status.There was no significant correlation between D2-40+ lymph vessel tumor emboli and PR and HER-2 expression.Conclusion D2-40 is a reliable marker of LVTE and improves the detection of LVTE compared to routine HE-staining.LVTE is related to the age,higher histologic grade,axillary node status and estrogen expression.
出处 《诊断病理学杂志》 CSCD 2011年第4期282-284,共3页 Chinese Journal of Diagnostic Pathology
关键词 淋巴管癌栓 乳腺癌 D2-40 Lymph vessel tumor emboli Breast cancer D2-40
  • 相关文献

参考文献9

  • 1Laser J, Cangiarella J, Singh B, et al. Invasive lobular carcinoma of the breast: role of endothelial lymphatic marker D2-40 [ J ]. Ann Clin Lab Sci[J]. 2008,38(2) :99 -104.
  • 2Marinho VF, Metze K, Sanches FS, et al. Lymph vascular invasion in invasive mammary carcinomas identified by the endothelial lymphatic marker D2-40 is associated with other indicators of poor prognosis[ .I]. BMC Cancer, 2008,29 ( 8 ) :64.
  • 3Kahn HJ, Bailey D, Marks A. Monoclonal antibody D2-40, a new marker of lymphatic endothelium, reacts with Kaposi' s sarcoma and a subset of angiosarcoma[ J]. Mol Pathol, 2002,15 (4) :434 - 440.
  • 4Rabban JT, Chen YY. D2-40 expression by breast myoepithelium: potential pitfalls in distinguishing intralymphatic carcinoma from in situ carcinoma [ J ]. Hum Pathol, 2008, 39 (2) : 175 - 183.
  • 5Vleugel MM, Bos R, van der Groep P, et al. Lack of lymphangiogenesis during breast carcinogenesis [ J ]. J Clin Pathol, 2004, 57(7):746-751.
  • 6Braun M, Flucke U, Debald M, et al. Detection of lymphovascular invasion in early breast cancer by D2-40 (podoplanin): a clinically useful predictor for axillary lymph node metastases[J]. Breast Cancer Res Treat, 2008,112(3 ): 503 -511.
  • 7Arnaout-Alkarain A, Kahn H J, Narod SA, et al. Significance of lymph vessel invasion identified by the endothelial lymphatic marker D2-40 in node negative breast cancer[J]. Mod Pathol, 2007,20(2) : 183 - 191.
  • 8Dent R, Trudeau M, Pritchard KI, et al. Triple-negative breast cancer: clinical features and patterns of recurrence [ J ]. Clin Cancer Res,2007, 13 ( 15 Pt 1 ) :4429 - 4434.
  • 9Goldhirsch A, Glick JH, Gelber RD, et al. Meeting highlights: international expert consensus on the primary therapy of early breast cancer 2005 [ J]. Ann Oncol, 2005, 16 ( 10 ) : 1569 - 1583.

同被引文献7

引证文献2

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部